Dermatologicals in Turkey
Dermatologicals registered slower retail value growth in 2017, compared with the review period CAGR. The main reason for the slowdown was the launch of many new products in the early review period, including Bepanthol Nappy Care Ointment, which stimulated high growth rates. The growth rate is expected to continue to slow over the forecast period due to maturity in hair loss treatments and nappy (diaper) rash treatments, for example.
Euromonitor International's Dermatologicals in Turkey report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2012-2016, allowing you to identify the sectors driving growth. Forecasts to 2021 illustrate how the market is set to change.
Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Dermatologicals market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
- DERMATOLOGICALS IN TURKEY
- Euromonitor International
- November 2017
- LIST OF CONTENTS AND TABLES
- Slower Value Growth in 2017
- Paediatric Dermatologicals Stimulates Value Growth
- Threat To Hair Loss Treatments
- Competitive Landscape
- International and Domestic Companies Remain Key Players
- Innovation Continues in Hair Loss Treatments
- New Pen Format in Topical Antifungals
- Category Data
- Table 1 Sales of Dermatologicals by Category: Value 2012-2017
- Table 2 Sales of Dermatologicals by Category: % Value Growth 2012-2017
- Table 3 NBO Company Shares of Dermatologicals: % Value 2013-2017
- Table 4 LBN Brand Shares of Dermatologicals: % Value 2014-2017
- Table 5 LBN Brand Shares of Hair Loss Treatments: % Value 2014-2017
- Table 6 Forecast Sales of Dermatologicals by Category: Value 2017-2022
- Table 7 Forecast Sales of Dermatologicals by Category: % Value Growth 2017-2022
- Executive Summary
- Consumer Health Continues To Develop in Turkey
- OTC Legislation Is Still Lacking in 2017
- Leading Pharmaceutical Players Focus on OTC
- Chemists/pharmacies Continues To Dominate Distribution
- Positive Outlook for the Forecast Period
- Market Indicators
- Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2012-2017
- Table 9 Life Expectancy at Birth 2012-2017
- Market Data
- Table 10 Sales of Consumer Health by Category: Value 2012-2017
- Table 11 Sales of Consumer Health by Category: % Value Growth 2012-2017
- Table 12 NBO Company Shares of Consumer Health: % Value 2013-2017
- Table 13 LBN Brand Shares of Consumer Health: % Value 2014-2017
- Table 14 Distribution of Consumer Health by Format: % Value 2012-2017
- Table 15 Distribution of Consumer Health by Format and Category: % Value 2017
- Table 16 Forecast Sales of Consumer Health by Category: Value 2017-2022
- Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2017-2022
- OTC Registration and Classification
- Vitamins and Dietary Supplements Registration and Classification
- Self-medication/self-care and Preventive Medicine
- Summary 1 Research Sources